We would love to hear your thoughts about our site and services, please take our survey here.
I see you were invested in HE1?
How much did the CEO invest before the news which took it above 1000%? Sorry it happens across AIM. Not really a reflection of reality plus I guess she was hoping for cheap options.
You need to convince yourself before convincing others.
So just recently you were claiming 99 % believe 201 is happening now you are saying it is not. Seems you are the thick one changing one thing to the other.
betterlife
Posted in: VAL
Posts: 279
Price: 8.10
Strong Buy
The gang of badgers11 Dec 2023 19:49
porky, soon i will get under your skin.it is christmas soon as you know.people who panics and sells on here must be following you everywhere .they still haven’t learned the lesson from your mistakes one after the other.1p drop they absolutely **** them self,2p rise they go over the moon.just because you pay £20,90 shillings a month ,doesn’t means that you are professional trader or know a faak all.you have been saying last 2 years they will rise at 4p. you are absolutely full off…. so many new babies on here reads your post they think you know all but unfortunately you don’t know f. all.when price is down your other allies nick also appears on the stage for some reason . nick also says on telegram that he doesn’t pay you for rubbish you dump on here , how weird!!you need to change the tactic anymore. you have been so boring. possibly most boring human/she on planet.i love dr adam’s replay your post on twitter says “get help” which most of us have been telling last 2-3 years.%99 of share holders believes val 201 is happening.you have got nothing to invest anymore because you lost all.i look your history, any shares you have been on, has gone bust or about to go bust.there isn’t any advice i can give you but, i can definitely recommend you to see a doctor. if you don’t have money to see doctor , i am sure dr adam will be very kind to see you. he is very generous man.
Not really. As stated yesterday for the merger to go ahead you likely need the board as it is at the moment so the merger goes ahead and the sub license gets executed following the conclusion of the merger.
Let the merger conclude and give it another month or two otherwise you are just shooting yourself in the foot. No point screwing it up on the finishing line after all this time.
Frustration should not get in the way of making stupid decisions at the wrong time. To be fair I don't even know who is really invested on these boards but I have a good idea of those that are not.
201 needs to conclude unless you want to release 1 billion shares at 1p next year. Conclusion of that can take the share price to any price along with other news.
New projects need funding and the 2 million 201 gives even more time for a CLX deal therefore potentially even meaning no placing for a very long time. The share price can hit all time highs if 201, 401 and CLX get completed but for that to happen we will likely need to 201 over the line first.
We got cash so we can wait a month or two and as far as I am concerned TRX has raised the money based on my analysis of all the statements released so far. Unless it is a scam which I highly doubt.
Ok let me piece all together all in my opinion but I think it makes sense.
1) Valirx would only sign the sub license if TRX had the money in place to pay Valirx the agreed amounts and for that to happen they would also need to have funding in place for the trials. Otherwise Valirx cannot sign the sub license.
2) The RNS on the 28 Sept 2023 confirmed that Valirx will receive the payments once the sub license was signed.
3) Suzy stated it should be a straightforward and fairly quick process to sign the sub licence once the merger is completed.
4) Public statement released by EUDA regarding TRX financing:
“We believe TheoremRx has strong access to capital and a robust pipeline of compounds addressing high-demand unmet therapeutic areas with near-term inflection points. Its project portfolio is also pre-selected for high upside, with minimal time and cost to reach key monetization milestones. By combining the respective strengths of our two companies’ platforms, we believe that we can help critical new biopharma treatments advance through the clinical trial process while creating significant value for shareholders.”
5) Although it says they believe if it was not the case TRX had the funding then the DD would very likely have failed by now.
Many of those that are posting here are not really invested so are not acting in our best interests.
My view is that action at this time is counter productive and would jeopardise the deal unless like I said it is Adam that comes on board. If it was any other shareholder I would question what they would bring to the table because as I am concerned they can give themselves options at any time at any price and if the share price is at a certain price then shareholders would likely have to agree. They collect an easy wage and walk away whilst we hold onto the baby at lower prices. It would just be a repeat of Suzy 3 years back.
If no delivery happens by the end of March or if the deal fails then it's fair to make some changes but I question it at this stage.
The merger needs the LOI in place if that is in doubt due to an EGM that would likely mean further delays or the merger being put at risk.
If this was near the start of the LOI i would agree but not at the concluding stage. That can only be tested by waiting a few weeks longer closer to the end of March although that is not an official deadline.
I have no doubt TRX has raised the funds so all this is not helpful at this time. Change might be good depending on the outcome but the timing is wrong so I would vote against it for now if it comes to it. It just creates more instability at the wrong time.
This does not favour existing holders but I don't see anyone selling in fact we might see buyers. Those here calling for change will nicely walk away if 201 failed so I don't think this helps the situation at this time.
As I said numerous times I would have waited until 31st March but I would think the outcome of the merger would be much sooner. If that failed then I would have pushed for changes as the damage would be at a point where it could not get worse.
I see it as a huge positive if it is Adam stepping forward but I don't want another Suzy or two. No time for apprentices and those trying to get a cheap salary and options.
Adam Hargreaves
Dr Adam Hargreaves is the founder of PathCelerate Limited, a contract research pharmaceutical efficacy and safety company. Spanning a 20-year career, he previously worked for AstraZeneca, and has interests and skills in preclinical and translational small molecule, biologic, and RNA-based pharmaceuticals. PathCelerate has provided preclinical and clinical drug discovery and development assistance to a number of global pharmaceutical companies, in addition to a wide and diverse range of small- and medium-sized biotechnology and medical device firms; assisting in the generation of numerous Investigational New Drug and Clinical Trial Application submissions.
Adam is a Fellow of the Royal College of Pathologists and is a board-certified Diplomate of the American College of Veterinary Pathology. His PhD research encompassed oncology medicine safety and he has held posts including President of the British Society of Toxicologic Pathology and Visiting Professor at the University of Surrey, where he lectures in pharmaceutical efficacy and safety. He is a keen investor in small-cap drug discovery and biotechnology AIM stocks, and takes a particular interest in how such companies attract both retail and institutional investment via portfolio expansion and pertinent news flow.
Look Adam on the BOD would be a dream come true for everyone and even better than the 201 deal.
If that is the case then shareholders have done well and we can finally get to where we should be.
I really hope it is Adam as he has a business mind and all the knowledge. His focus will be driving the SP forward not the long term bull chit we hear every year forever.
Not important how deep I am. I hold and I have not sold because I see value at this price. What will make it worse for me is if I see this go up 500% plus next week or soon.
I fully expect the merger to be successful and 201 to be signed soon after therefore I expect a huge rise from this market cap.
Suzy confirmed that LOI is in place and if it was not they would have to announce. Add that to the fact they spent 4 months formally working on the merger and many months before that. Highly unlikely to fail imo. If it goes ahead the rise from here could really be anything from 300-1000% imo given the current market cap.
You also don't update a website with your profiles if the news is about to be bad. Figure it out. What an opportunity to buy but not much shares left and slowly we creep up now.
LOI last time took this to 65p with 65 million shares but with not funding no lab no CLX.
Now we have all that but 130 million shares.
We can rise like HE1 up 500% as the milestones will be huge relative to the market cap. Also the extra 2 million means it is highly likely we get a preclinical deal before any placing in the future and that would be 10/20 million upfront.
Likely the final build up before merger news announced.
A gifted leader, Ken’s high standards in science and business operations serve as an example and impetus to others and to the formation of successful new biotechnology companies. Ken has successfully raised more than $1 billion of capital to support translational research and to enable new biotechnology companies to move from scientific concepts to commercialized products.
Well Adam was thinking 10/20 million upfront for CLX alone. The data and science for that is very strong. Don't need peer review at this stage it can be sold.
Same as the other compounds. Full patent life positive early results can fetch a few millions each.
IF the assets are worth more than 20/30 million in total then why not list for a takeover?
These guys are not getting anywhere so might as well sell the business. If someone can go inside and arrange for this to happen that would be good.
Sell lab, CLX and if they can get 201 over the line and sign the deal list the business for sale. Might then get 30/40 million.
The strategy and the lab is fine but they should not spend anymore until they deliver big. How else would you develop early stage compounds or do you just keep 201, 301 and 401 and nothing else. You can out license projects but this will cost more. Also revenue is needed to attract large investments.
The execution is poor. We should be more than 20p so with good news especially 201 then we can rise big. Officially they have projected until H2 in 2025 not September 2024 but if 201 completes with some decent lab contracts it will be much longer. Porky claims to follow the broker report but takes out what he wants to fit his agenda.
Based on assets we should easily be 20p plus.
I would give it until the end of March to see what they can do as I expect 201 to complete. Pointless if you are invested and moaning on here and dragging the price even lower only for the other traders on here to buy much cheaper whilst you lose money.
News will come. Changing them at this stage means we only go backwards. I would say by the end of March they would have had enough of a chance.
Again most here are not invested or have lost most of the money over the years so a different agenda.
I agree that a poor job has been done so far in terms of delivery. Not denying it. I just think if we get a new BOD then it will need at least 3-5 dilutions to see any real value. Don't assume instant success as it will take a considerable amount of time to understand the projects, build connections and modify the strategy. Look at APTAMER as an example and if another placing happens in that stock it will likely be far lower than where it is now.
Like HE1 by getting 201 over the line and getting out other news this can turn around significantly. The additional cash will give us at least 2 years worth of capital without lab revenue or other deals. I might be down but the only way I see a return is if this BOD delivers and only if they deliver. Anyone else unless it is Adam then basically existing holders will be washed away. The company could succeed under new management but it will need additional money and time so not great for us.
I understand the merger needs to be completed by the end of March. The fact that it has been ongoing must mean it will likely succeed so no harm done waiting until the end of March. If no progress is made then I would have nothing more to say.
At this market cap we have it all to gain and with cash for 12 months I would expect some positive news. 401 is also due to complete this year and CLX news will come good or bad but at this market cap I fancy my chances of this going back up.